Xi Jiang
Impact in
-
- NF-κB Signaling Pathways
-
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- Signaling Pathways in Disease 5
- Ubiquitin and proteasome pathways 2
-
- Viral Infections and Immunology Research 3
- Cardiac Fibrosis and Remodeling 3
- Co-authors
- Hongliang Li (9 shared papers)Pi‐Xiao Wang (7 shared papers)Ke‐Qiong Deng (5 shared papers)Yan‐Xiao Ji (5 shared papers)Xiao‐Jing Zhang (3 shared papers)Zan Huang (3 shared papers)Xue‐Yong Zhu (4 shared papers)Yichao Zhao (2 shared papers)
- Journals
- Hypertension (3 papers)Nature Communications (3 papers)Phytotherapy Research (2 papers)Frontiers in Medicine (2 papers)Frontiers in Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Xi Jiang
28 papers receiving 761 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 108
- Immunology 156
- Cardiology and Cardiovascular Medicine 156
- Hepatology 50
- Epidemiology 172
Countries citing papers authored by Xi Jiang
This map shows the geographic impact of Xi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Jiang more than expected).
Fields of papers citing papers by Xi Jiang
This network shows the impact of papers produced by Xi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Jiang. The network helps show where Xi Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 150 | |
| 2 | 2016 | 111 | |
| 3 | 2016 | 60 | |
| 4 | 2015 | 50 | |
| 5 | 2016 | 49 | |
| 6 | 2018 | 47 | |
| 7 | 2016 | 42 | |
| 8 | 2016 | 38 | |
| 9 | 2017 | 35 | |
| 10 | 2016 | 32 | |
| 11 | 2022 | 27 | |
| 12 | 2020 | 20 | |
| 13 | Rotaviruses, caliciviruses, astroviruses, enteric adenoviruses, and other diarrheic viruses. | 2006 | 17 |
| 14 | 2022 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2023 | 11 | |
| 17 | 2024 | 11 | |
| 18 | 2022 | 11 | |
| 19 | 2009 | 7 | |
| 20 | 2018 | 5 |
About Xi Jiang
Xi Jiang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Immunology, Oncology and Epidemiology, having authored 29 papers that have together received 770 indexed citations. Recurring topics across this work include interferon and immune responses (5 papers), Signaling Pathways in Disease (5 papers), NF-κB Signaling Pathways (3 papers), Viral Infections and Immunology Research (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Ubiquitin and proteasome pathways (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (108 citations), Immunology (156 citations), Cardiology and Cardiovascular Medicine (156 citations), Hepatology (50 citations) and Epidemiology (172 citations). Xi Jiang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Hongliang Li, Pi‐Xiao Wang, Ke‐Qiong Deng, Yan‐Xiao Ji, Xiao‐Jing Zhang, Zan Huang, Xue‐Yong Zhu, Yichao Zhao, Peng Zhang and Peng Zhang. Their work appears in journals such as Hypertension, Nature Communications, Phytotherapy Research, Frontiers in Medicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.